{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:44:05Z","timestamp":1793339045139,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Ministry of Science and Technology of China","award":["2018YFE0201603"],"award-info":[{"award-number":["2018YFE0201603"]}]},{"name":"Ministry of Science and Technology of China","award":["2020YFE0201600"],"award-info":[{"award-number":["2020YFE0201600"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["2017SHZDZX01"],"award-info":[{"award-number":["2017SHZDZX01"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["16JC1400500"],"award-info":[{"award-number":["16JC1400500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["16411954800"],"award-info":[{"award-number":["16411954800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873660"],"award-info":[{"award-number":["81873660"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31821002"],"award-info":[{"award-number":["31821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100849"],"award-info":[{"award-number":["82100849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Talent Project","award":["20PJ1402300"],"award-info":[{"award-number":["20PJ1402300"]}]},{"name":"Foundation for Young Scholar from Zhongshan Hospital, Fudan University","award":["2021ZSQN07"],"award-info":[{"award-number":["2021ZSQN07"]}]},{"name":"Foundations from Zhongshan Hospital, Fudan University","award":["2020ZSLC58"],"award-info":[{"award-number":["2020ZSLC58"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12072-022-10439-z","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:03:55Z","timestamp":1667491435000},"page":"313-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiaopeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqige","family":"Aleteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huandong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-0165","authenticated-orcid":false,"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"issue":"3","key":"10439_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70(3):531\u2013544","journal-title":"J Hepatol"},{"issue":"11","key":"10439_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901\u2013910","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10439_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","volume":"69","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69:564\u2013568","journal-title":"Gut"},{"issue":"4","key":"10439_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904","journal-title":"J Hepatol"},{"issue":"3","key":"10439_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","volume":"61","author":"VW Wong","year":"2012","unstructured":"Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409\u2013415","journal-title":"Gut"},{"issue":"5","key":"10439_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577\u20131586","journal-title":"Hepatology"},{"issue":"1","key":"10439_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","volume":"288","author":"B Zou","year":"2020","unstructured":"Zou B, Yeo YH, Nguyen VH, Cheung R, Ingelsson E, Nguyen MH. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016. J Intern Med. 2020;288(1):139\u2013151","journal-title":"J Intern Med"},{"issue":"4","key":"10439_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","volume":"54","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Q, Sun Y, Zhao X, Kong Y, Ou X, et al. The prevalence of lean\/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2020;54(4):378\u2013387","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10439_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017;46(2):85\u201395","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10439_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u2013752","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10439_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/apt.15372","volume":"50","author":"MF Xia","year":"2019","unstructured":"Xia MF, Chen LY, Wu L, Ma H, Li Q, Aleteng Q, et al. The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study. Aliment Pharmacol Ther. 2019;50(6):684\u2013695","journal-title":"Aliment Pharmacol Ther"},{"key":"10439_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","volume":"59","author":"HC Hong","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean sarcopenic obesity study. Hepatology. 2014;59:1772\u20131778","journal-title":"Hepatology"},{"key":"10439_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66:123\u2013131","journal-title":"J Hepatol"},{"key":"10439_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/apt.13889","volume":"45","author":"S Petta","year":"2017","unstructured":"Petta S, Ciminnisi S, Di Marco V, Cabibi D, Camm\u00e0 C, Licata A, et al. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017;45:510\u2013518","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10439_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jhep.2020.10.019","volume":"74","author":"M Xia","year":"2021","unstructured":"Xia M, Zeng H, Wang S, Tang H, Gao X. Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling. J Hepatol. 2021;74(4):974\u2013977","journal-title":"J Hepatol"},{"key":"10439_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/oby.2011.302","volume":"20","author":"MF Xia","year":"2012","unstructured":"Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, et al. Standardized ultrasound hepatic\/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring). 2012;20:444\u2013452","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10439_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21(2):93\u2013111","journal-title":"J Am Soc Echocardiogr"},{"issue":"20","key":"10439_CR18","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","volume":"90","author":"B Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez B, Holmes E, Heude C, Tolson RF, Harvey N, Lodge SL, et al. Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human serum and plasma by 1 H NMR spectroscopy in a multilaboratory trial. Anal Chem. 2018;90(20):11962\u201311971","journal-title":"Anal Chem"},{"issue":"6","key":"10439_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/apt.16772","volume":"55","author":"MF Xia","year":"2022","unstructured":"Xia MF, Ma S, Huang QX, Zeng HL, Ge JY, Xu WJ, et al. NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study. Aliment Pharmacol Ther. 2022;55(6):705\u2013721","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10439_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402","journal-title":"J Hepatol"},{"issue":"2","key":"10439_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101","journal-title":"J Am Med Dir Assoc"},{"issue":"10191","key":"10439_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636\u20132646","journal-title":"Lancet"},{"issue":"6","key":"10439_CR23","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","volume":"66","author":"RA Bhanji","year":"2017","unstructured":"Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017;66(6):2055\u20132065","journal-title":"Hepatology"},{"issue":"6","key":"10439_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","volume":"13","author":"JA Kim","year":"2019","unstructured":"Kim JA, Choi KM. Sarcopenia and fatty liver disease. Hepatol Int. 2019;13(6):674\u2013687","journal-title":"Hepatol Int"},{"issue":"6553","key":"10439_CR25","doi-asserted-by":"publisher","first-page":"eabe6729","DOI":"10.1126\/science.abe6729","volume":"373","author":"YH Han","year":"2021","unstructured":"Han YH, Onufer EJ, Huang LH, Sprung RW, Davidson WS, Czepielewski RS, et al. Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science. 2021;373(6553):eabe6729","journal-title":"Science"},{"issue":"1","key":"10439_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-020-01595-w","volume":"18","author":"G Xie","year":"2020","unstructured":"Xie G, Wang X, Wei R, Wang J, Zhao A, Chen T, et al. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med. 2020;18(1):144","journal-title":"BMC Med"},{"issue":"5","key":"10439_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cmet.2021.03.025","volume":"33","author":"D Yu","year":"2021","unstructured":"Yu D, Richardson NE, Green CL, Spicer AB, Murphy ME, Flores V, et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 2021;33(5):905-922.e6","journal-title":"Cell Metab"},{"issue":"2","key":"10439_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.clnu.2020.06.003","volume":"40","author":"MF Xia","year":"2021","unstructured":"Xia MF, Chen LY, Wu L, Ma H, Li XM, Li Q, et al. Sarcopenia, sarcopenic overweight\/obesity and risk of cardiovascular disease and cardiac arrhythmia: a cross-sectional study. Clin Nutr. 2021;40(2):571\u2013580","journal-title":"Clin Nutr"},{"issue":"5","key":"10439_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/ATVBAHA.116.307156","volume":"36","author":"BJ Ko","year":"2016","unstructured":"Ko BJ, Chang Y, Jung HS, Yun KE, Kim CW, Park HS, et al. Relationship between low relative muscle mass and coronary artery calcification in healthy adults. Arterioscler Thromb Vasc Biol. 2016;36(5):1016\u20131021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10439_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290\u2013298","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10439_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.119.043581","volume":"142","author":"Y Xu","year":"2020","unstructured":"Xu Y, Jiang H, Li L, Chen F, Liu Y, Zhou M, et al. Branched-chain amino acid catabolism promotes thrombosis risk by enhancing tropomodulin-3 propionylation in platelets. Circulation. 2020;142(1):49\u201364","journal-title":"Circulation"},{"key":"10439_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1159\/000518412","volume":"68","author":"S Yeung","year":"2022","unstructured":"Yeung S, Zhu Z, Kwok T, Woo J. Serum amino acids patterns and 4-year sarcopenia risk in community-dwelling chinese older adults. Gerontology. 2022;68:736\u2013745","journal-title":"Gerontology"},{"key":"10439_CR33","doi-asserted-by":"publisher","first-page":"681444","DOI":"10.3389\/fcvm.2021.681444","volume":"8","author":"S Ma","year":"2021","unstructured":"Ma S, Xia M, Gao X. Biomarker discovery in atherosclerotic diseases using quantitative nuclear magnetic resonance metabolomics. Front Cardiovasc Med. 2021;8:681444","journal-title":"Front Cardiovasc Med"},{"key":"10439_CR34","doi-asserted-by":"publisher","first-page":"111668","DOI":"10.1016\/j.exger.2021.111668","volume":"159","author":"H Gong","year":"2022","unstructured":"Gong H, Liu Y, Lyu X, Dong L, Zhang X. Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function. Exp Gerontol. 2022;159:111668","journal-title":"Exp Gerontol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10439-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T08:35:14Z","timestamp":1681979714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10439-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10439"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10439-z","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xiaopeng Zhu declares that there is no duality of interest. Qingxia Huang declares that there is no duality of interest. Shuai Ma declares that there is no duality of interest. Lingyan Chen declares that there is no duality of interest. Qi Wu declares that there is no duality of interest. Li Wu declares that there is no duality of interest. Hui Ma declares that there is no duality of interest. Xiaoming Li declares that there is no duality of interest. Qian Li declares that there is no duality of interest. Qiqige Aleteng declares that there is no duality of interest. Yu Hu declares that there is no duality of interest. Wanyuan He declares that there is no duality of interest. Jian Gao declares that there is no duality of interest. Huandong Lin declares that there is no duality of interest. Huiru Tang declares that there is no duality of interest. Xin Gao declares that there is no duality of interest. Mingfeng Xia declares that there is no duality of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by the Research Ethics Committees of Zhongshan Hospital, Fudan University (No. 2008-119 and B2013-132).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each participant provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}